IP Library Granted Patent US 11,751,654
Granted Patent B2
US 11,751,654 · App. 17/462,962 · Granted Sep 12, 2023

Contact lens packaging

Inventors: Baxter J. Lansing (Ontario, NY); Arvind M. Rao (Rochester, NY); James Dibella (Macedon, NY); Joseph W. Hoff (Fairport, NY)
Assignee: Bausch + Lomb Ireland Limited
A45C11/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,751,654
App. No.
17/462,962
Granted
Sep 12, 2023
Kind
B2
Abstract

A contact lens package includes a first layer, a support coupled to the first layer, a lens, and a second layer. The support includes a scaffold and a porous member attached to the scaffold where the porous member includes a curved surface. The lens includes an anterior surface and a posterior surface, and the posterior surface of the lens is disposed on the curved surface of the porous member. The second layer is coupled to the first layer to seal the support and the lens between the first layer and the second layer.

Claims (30)

1. A contact lens package comprising:

a first layer;

a support coupled to the first layer, the support including a dome-shaped scaffold and a dome-shaped hydrogel is formed around the domed-shaped scaffold;

a lens including an anterior surface and a posterior surface, wherein the posterior surface of the lens is disposed on the dome-shaped hydrogel; and

a second layer coupled to the first layer to seal the support and the lens between the first layer and the second layer.

2. The contact lens package of claim 1 , wherein the first layer is a rigid plastic tray and wherein the second layer is a foil lid stock.

3. The contact lens package of claim 1 , wherein the scaffold is integrally formed with the first layer.

4. The contact lens package of claim 1 , wherein the first layer is a foil lid stock and the second layer is a rigid plastic blister.

5. The contact lens package of claim 1 , wherein the dome-shaped hydrogel is a sintered material.

6. The contact lens package of claim 1 , wherein the domed-shaped hydrogel exhibits antimicrobial properties.

7. The contact lens package of claim 1 , wherein the hydrogel is capable of absorbing at least 5% of a buffered saline solution.

8. The contact lens package of claim 7 , wherein the buffered saline solution contains antimicrobial agents that can be diffused into the lens.

9. The contact lens package of claim 7 , wherein the buffered saline solution contains wetting agents that can be imparted onto the lens.

10. The contact lens package of claim 7 , wherein the buffered saline solution contains antihistamine that can be diffused into the lens.

11. The contact lens package of claim 7 , wherein the buffered saline solution contains nutraceuticals that can be diffused into the lens.

12. The contact lens package of claim 7 , wherein the buffered saline solution contains osmoprotectants that can be diffused into the lens.

13. The contact lens package of claim 7 , wherein the buffered saline solution contains additives selected from the group consisting of erythritol, glycerol, mannitol, sorbitol, and propylene glycol.

14. The contact lens package of claim 7 , wherein the buffered saline solution contains one or more block copolymers comprising a combination of polyethylene oxide and polypropylene oxide blocks.

15. The contact lens package of claim 1 , wherein at least one of the first layer and the second layer include perforations.

16. A contact lens package comprising:

a base;

a cover coupled to the base, the base and the cover defining a receptacle for a contact lens;

a support disposed within the receptacle, the support including a dome-shaped hydrogel and a dome-shaped scaffold, wherein the dome-shaped hydrogel is formed around the dome-shaped scaffold; and

a contact lens including an anterior surface and a posterior surface, wherein the posterior surface of the contact lens is disposed on the domed-shaped hydrogel.

17. The contact lens package of claim 16 , wherein the support is coupled to the base.

18. The contact lens package of claim 16 , wherein the support is coupled to the cover.

19. The contact lens package of claim 16 , wherein the hydrogel is capable of absorbing a buffered saline solution.

20. The contact lens package of claim 16 , wherein the hydrogel exhibits antimicrobial properties.

21. The contact lens package of claim 16 , wherein the cover includes perforations.

22. The contact lens package of claim 16 , wherein the cover is hermetically sealed to the base.

Assignments (10)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (064712/0167) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A. AS SUCCESSOR AGENT
Reel/Frame 072460/0637 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 058205/0889) Recorded Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 067131/0662 →
SECURITY INTEREST Recorded Feb 12, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066552/0041 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 24, 2023
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 064712/0167 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 058205/0843) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061778/0001 →
SECURITY INTEREST Recorded Nov 24, 2021
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH+LOMB IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 058205/0889 →
SECURITY INTEREST Recorded Nov 24, 2021
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH+LOMB IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; SOLTA MEDICAL IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 058205/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2021
From: LANSING, BAXTER J.; RAO, ARVIND M.; DIBELLA, JAMES; HOFF, JOSEPH W.
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 057345/0762 →
Continuity (1)
Related Publication 20230060534A1 · Mar 2, 2023
Cited By (7)
US 12,187,522 US 12,458,121 US 12,503,289 US 12,667,172 US 12,702,588 US 12,715,674 US 12,715,681